Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Shixin Pharmaceutical Co., Ltd., formerly known as Guangdong Green Pharmaceutical, is a prominent pharmaceutical manufacturer headquartered in Jieyang, Guangdong Province, China. Established in 2000, the company focuses on the research, development, and large-scale production of a wide array of therapeutic products, including large and small volume injections, tablets, capsules, and granules. Its product portfolio spans multiple critical areas such as the digestive, respiratory, nervous, and cardiovascular systems, with key offerings like Flumazenil, Oxiracetam, and various over-the-counter (OTC) medications. The company operates state-of-the-art, GMP-certified manufacturing facilities and has invested significantly in R&D, including collaborations with academic institutions like Shenyang Pharmaceutical University. With an annual production capacity of hundreds of millions of units and a strong presence in the Chinese domestic market, Guangdong Shixin Pharmaceutical is a key contributor to the regional healthcare sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Shixin Pharmaceutical.